Clinical Trial Update: A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating RO7204239 in combination with tirzepatide for obesity or overweight with at least one weight-related comorbidity; currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• MOUNJARO (tirzepatide)
• RO7204239

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Obesity, Overweight | Phase 2 | Status: ACTIVE_NOT_RECRUITING